Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aerovate Therapeutics, Inc.

2.75
+0.07002.61%
Post-market: 2.790.0400+1.45%19:40 EDT
Volume:177.71K
Turnover:484.56K
Market Cap:79.71M
PE:-1.13
High:2.79
Open:2.68
Low:2.63
Close:2.68
Loading ...
Aug 14, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 14, 2023

Major Issues Report

Form 8-K - Current report
Aug 07, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 28, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 12, 2023

Major Issues Report

Form 8-K - Current report
Jul 06, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 05, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 03, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 27, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jun 21, 2023

Major Issues Report

Form 8-K - Current report
Jun 08, 2023

Major Issues Report

Form 8-K - Current report
Jun 06, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 05, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 19, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 15, 2023

Major Issues Report

Form 8-K - Current report
May 15, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
May 05, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities